Target intelligence / Profile preview

Bile acid pool and bile flow

Molecular classification
Other
01

Overview

The bile acid pool and bile flow represent the integrated physiological system responsible for the synthesis, secretion, and recycling of bile acids through the enterohepatic circulation (StatPearls, 2023). Bile acids are synthesized from cholesterol in the liver, stored in the gallbladder, and released into the duodenum to facilitate the digestion and absorption of lipids and fat-soluble vitamins (NIH, 2022). Beyond digestion, the bile acid pool acts as a complex signaling network, activating receptors such as the Farnesoid X Receptor (FXR) and TGR5 to regulate glucose and lipid metabolism (Nature Reviews Gastroenterology & Hepatology, 2017). Disruptions in bile flow (cholestasis) or alterations in the bile acid pool size and composition are central to the pathogenesis of various hepatobiliary and metabolic diseases, including primary biliary cholangitis and gallstone disease (PubMed, 2021). Therapeutic strategies often focus on specific molecular components of this system, such as transporters (e.g., ASBT) or nuclear receptors, to restore homeostasis or reduce toxic bile acid accumulation (Journal of Hepatology, 2020).

Other names
Enterohepatic circulationBile acid homeostasisBiliary secretionBile acid pool
02

Mechanism of action

Therapeutic modulation involves the sequestration of bile acids in the intestine, activation of nuclear receptors (FXR) to suppress synthesis, or inhibition of the apical sodium-dependent bile acid transporter (ASBT) to interrupt enterohepatic circulation (Liver International, 2022).

03

Biological functions

Lipid digestionCholesterol homeostasisMetabolic signalingExcretion of waste products
04

Disease associations

CholestasisPrimary biliary cholangitisPrimary sclerosing cholangitisGallstonesNonalcoholic steatohepatitis (NASH)Bile acid malabsorption
05

Safety considerations

PruritusMalabsorption of fat-soluble vitaminsDiarrheaGastrointestinal discomfort
06

Interacting drugs

Ursodeoxycholic acid

5 more in the full profile.

07

Biomarkers

Serum total bile acids7α-hydroxy-4-cholesten-3-one (C4)Fibroblast growth factor 19 (FGF19)

Beyond the preview

Go deeper on Bile acid pool and bile flow.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bile acid pool and bile flow.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call